Join us at ISTH 2025 Booth #321 Exhibit Hours June 22–24, 10:00 AM–5:00 PM ET

Introducing Our Next Generation of Hemostasis Testing Innovation

Join us for a look at our new ACL TOP® Family 70 Series Hemostasis Testing Systems*

Also at the booth:

Speak with your Werfen rep or signup to request an instrument demonstration or meeting.

Presentation Theater

Bridging the Gap: Lab Testing Strategies for Transitioning Patients from DOACs to Unfractionated Heparin

June 23, 1:45-2:30 PM ET
Exhibit Hall, Presentation Theater 2

As part of the ISTH Congress 2025, you’re invited to attend our education Presentation Theater, featuring Dr. Deepa J Arachchillage, who will discuss strategies for transitioning patients from direct oral anticoagulants (DOAC) to unfractionated heparin (UFH).

A Q&A session with Dr. Arachchillage will follow the presentation.

Presentation Theater Objectives

• Assess current heparin monitoring recommendations (UFH and low molecular weight heparin), testing practice and challenges

• Review the evolution of DOACs, including current availability and indications for use, and recommendations for laboratory measurement
• Describe potential strategies for monitoring UFH in a patient recently transitioned from an anti-Xa DOAC

 

Featured Speaker

Deepa J. Arachchillage, MD      Consultant Haematologist and Honorary Senior Lecturer      MRC CARP Fellow      Imperial College and Imperial College Healthcare      London, England

 

*Not available in all countries.